BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29236257)

  • 1. Identifying RISC Components Using Ago2 Immunoprecipitation and Mass Spectrometry.
    Yi T
    Methods Mol Biol; 2018; 1720():149-159. PubMed ID: 29236257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eIF1A augments Ago2-mediated Dicer-independent miRNA biogenesis and RNA interference.
    Yi T; Arthanari H; Akabayov B; Song H; Papadopoulos E; Qi HH; Jedrychowski M; Güttler T; Guo C; Luna RE; Gygi SP; Huang SA; Wagner G
    Nat Commun; 2015 May; 6():7194. PubMed ID: 26018492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and specific purification of Argonaute-small RNA complexes from crude cell lysates.
    Flores-Jasso CF; Salomon WE; Zamore PD
    RNA; 2013 Feb; 19(2):271-9. PubMed ID: 23249751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF90 interacts with components of RISC and modulates association of Ago2 with mRNA.
    Grasso G; Akkawi C; Franckhauser C; Nait-Saidi R; Bello M; Barbier J; Kiernan R
    BMC Biol; 2022 Sep; 20(1):194. PubMed ID: 36050755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ago2-miRNA-co-IP Assay to Study TGF- β1 Mediated Recruitment of miRNA to the RISC in CFBE Cells.
    Mitash N; Donovan JE; Swiatecka-Urban A
    J Vis Exp; 2020 Jul; (161):. PubMed ID: 32894261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarifying mammalian RISC assembly in vitro.
    Tan GS; Garchow BG; Liu X; Metzler D; Kiriakidou M
    BMC Mol Biol; 2011 Apr; 12():19. PubMed ID: 21529364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleavage of the star strand facilitates assembly of some microRNAs into Ago2-containing silencing complexes in mammals.
    Shin C
    Mol Cells; 2008 Sep; 26(3):308-13. PubMed ID: 18728384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolyl 4-hydroxylation regulates Argonaute 2 stability.
    Qi HH; Ongusaha PP; Myllyharju J; Cheng D; Pakkanen O; Shi Y; Lee SW; Peng J; Shi Y
    Nature; 2008 Sep; 455(7211):421-4. PubMed ID: 18690212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PABPC1 interacts with AGO2 and is responsible for the microRNA mediated gene silencing in high grade hepatocellular carcinoma.
    Zhang H; Sheng C; Yin Y; Wen S; Yang G; Cheng Z; Zhu Q
    Cancer Lett; 2015 Oct; 367(1):49-57. PubMed ID: 26188282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The co-chaperones Fkbp4/5 control Argonaute2 expression and facilitate RISC assembly.
    Martinez NJ; Chang HM; Borrajo Jde R; Gregory RI
    RNA; 2013 Nov; 19(11):1583-93. PubMed ID: 24049110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IP.
    Meier J; Hovestadt V; Zapatka M; Pscherer A; Lichter P; Seiffert M
    RNA Biol; 2013 Jun; 10(6):1018-29. PubMed ID: 23673373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ago-TNRC6 triggers microRNA-mediated decay by promoting two deadenylation steps.
    Chen CY; Zheng D; Xia Z; Shyu AB
    Nat Struct Mol Biol; 2009 Nov; 16(11):1160-6. PubMed ID: 19838187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMOylation of TARBP2 regulates miRNA/siRNA efficiency.
    Chen C; Zhu C; Huang J; Zhao X; Deng R; Zhang H; Dou J; Chen Q; Xu M; Yuan H; Wang Y; Yu J
    Nat Commun; 2015 Nov; 6():8899. PubMed ID: 26582366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody.
    Ikeda K; Satoh M; Pauley KM; Fritzler MJ; Reeves WH; Chan EK
    J Immunol Methods; 2006 Dec; 317(1-2):38-44. PubMed ID: 17054975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miRNA biogenesis factors, p72/DDX17 and KHSRP regulate the protein level of Ago2 in human cells.
    Connerty P; Bajan S; Remenyi J; Fuller-Pace FV; Hutvagner G
    Biochim Biophys Acta; 2016 Oct; 1859(10):1299-305. PubMed ID: 27478153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded RNA-binding activities of mammalian Argonaute 2.
    Tan GS; Garchow BG; Liu X; Yeung J; Morris JP; Cuellar TL; McManus MT; Kiriakidou M
    Nucleic Acids Res; 2009 Dec; 37(22):7533-45. PubMed ID: 19808937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro RNA cleavage assay for Argonaute-family proteins.
    Miyoshi K; Uejima H; Nagami-Okada T; Siomi H; Siomi MC
    Methods Mol Biol; 2008; 442():29-43. PubMed ID: 18369776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of pre-RISC to holo-RISC by Ago2 during assembly of RNAi complexes.
    Kim K; Lee YS; Carthew RW
    RNA; 2007 Jan; 13(1):22-9. PubMed ID: 17123955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro reconstitution of the human RISC-loading complex.
    MacRae IJ; Ma E; Zhou M; Robinson CV; Doudna JA
    Proc Natl Acad Sci U S A; 2008 Jan; 105(2):512-7. PubMed ID: 18178619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Formation of Plant RNA-Induced Silencing Complexes Using an Extract of Evacuolated Tobacco Protoplasts.
    Iki T; Ishikawa M; Yoshikawa M
    Methods Mol Biol; 2017; 1640():39-53. PubMed ID: 28608333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.